应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
CBLL Ceribell
交易中 12-19 12:43:21 EST
26.21
-0.71
-2.64%
最高
27.62
最低
26.05
成交量
6.54万
今开
26.53
昨收
26.92
日振幅
5.83%
总市值
9.39亿
流通市值
7.04亿
总股本
3,582万
成交额
172.97万
换手率
0.24%
流通股本
2,686万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Ceribell, Inc.2024财年第三财季实现净利润-10.42百万美元
市场透视 · 11-19
Ceribell, Inc.2024财年第三财季实现净利润-10.42百万美元
BUZZ-摩根大通给予 CeriBell "增持 "评级
Reuters · 11-06
BUZZ-摩根大通给予 CeriBell "增持 "评级
美国研究综述-塞拉尼斯公司、Disc Medicine、Editas Medicine
Reuters · 11-05
美国研究综述-塞拉尼斯公司、Disc Medicine、Editas Medicine
加载更多
公司概况
公司名称:
Ceribell
所属市场:
NASDAQ
上市日期:
--
主营业务:
CeriBell, Inc.于2014年8月29日在特拉华州注册成立。他们是一家处于商业阶段的医疗技术公司,专注于改变严重神经系统疾病患者的诊断和管理。他们开发了Ceribell系统,这是一种新颖的护理点脑电图(“EEG”)平台,专门用于满足急性护理环境中患者未满足的需求。Ceribell系统将专有、高度便携、可快速部署的硬件与复杂的人工智能(“AI”)驱动的算法相结合,实现了对神经系统疾病患者的快速诊断和持续监测。Ceribell系统通过人工智能的力量使脑电图更容易获取并实现持续监测,使临床医生能够在急性护理环境中更快、更准确地诊断和管理有癫痫发作风险的患者,从而改善患者的预后以及医院和支付者的经济效益。
发行价格:
--
{"stockData":{"symbol":"CBLL","market":"US","secType":"STK","nameCN":"Ceribell","latestPrice":26.21,"timestamp":1734630192496,"preClose":26.92,"halted":0,"volume":65358,"delay":0,"floatShares":26862891,"shares":35824244,"eps":-6.56101,"marketStatus":"交易中","marketStatusCode":2,"change":-0.71,"latestTime":"12-19 12:43:21 EST","open":26.53,"high":27.62,"low":26.05,"amount":1729746.004896,"amplitude":0.058321,"askPrice":26.31,"askSize":105,"bidPrice":26.11,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-6.56101,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1734642000000},"adr":0,"listingDate":1728619200000,"adjPreClose":26.92,"preHourTrading":{"tag":"盘前","latestPrice":26.62,"preClose":26.92,"latestTime":"09:29 EST","volume":180,"amount":4794.79986,"timestamp":1734618588035},"postHourTrading":{"tag":"盘后","latestPrice":26.92,"preClose":26.92,"latestTime":"16:37 EST","volume":4706,"amount":126685.51,"timestamp":1734557859534},"volumeRatio":0.434891},"requestUrl":"/m/hq/s/CBLL","defaultTab":"news","newsList":[{"id":"2484130579","title":"Ceribell, Inc.2024财年第三财季实现净利润-10.42百万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484130579","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484130579?lang=zh_cn&edition=full","pubTime":"2024-11-19 18:00","pubTimestamp":1732010430,"startTime":"0","endTime":"0","summary":"11月19日,Ceribell, Inc.公布财报,公告显示公司2024财年第三财季净利润为-10.42百万美元;其中营业收入为17.20百万美元,每股基本收益为-0.29美元。机构评级:截至2024年11月19日,当前有4家机构对Ceribell, Inc.目标价做出预测,其中目标均价为31.50美元,其中最低目标价为31.00美元,最高目标价为32.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119180151a24562c0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119180151a24562c0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CBLL"],"gpt_icon":0},{"id":"2481873146","title":"BUZZ-摩根大通给予 CeriBell \"增持 \"评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2481873146","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481873146?lang=zh_cn&edition=full","pubTime":"2024-11-06 00:36","pubTimestamp":1730824568,"startTime":"0","endTime":"0","summary":" 11月5日 - ** 医疗技术公司 CeriBell 的 股价上涨 2.4% 至 26.87 美元** 摩根大通给予CBLL \"增持 \"评级** 券商称该公司开发了一种便携式硬件和人工智能驱动的软件,用于诊断和监测医院环境中的非惊厥性癫痫发作患者。** 摩根大通补充道,CBLL 在高度低渗透的急性护理癫痫发作市场开展业务,该市场价值约 30 亿美元,有拓展新临床适应症的空间。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CBLL"],"gpt_icon":0},{"id":"2481508022","title":"美国研究综述-塞拉尼斯公司、Disc Medicine、Editas Medicine","url":"https://stock-news.laohu8.com/highlight/detail?id=2481508022","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481508022?lang=zh_cn&edition=full","pubTime":"2024-11-05 20:32","pubTimestamp":1730809940,"startTime":"0","endTime":"0","summary":" 路透11月5日 - 华尔街证券分析师周二调整了对塞拉尼斯公司、Disc Medicine 和 Editas Medicine 等几家美国上市公司的评级和目标价。* Disc Medicine Inc :雷蒙德-詹姆斯将其评级从 \"跑赢大盘 \"上调至 \"强力买入\"。* Editas Medicine Inc :雷蒙德-詹姆斯将其评级从 \"跑赢大市 \"下调至 \"跑赢大市\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CHH","CNC","ABG","HIMS","AN","LU1496350502.SGD","CI","BWIN","BMRN","ADVM","LU0289739699.SGD","ATUS","ARES","ARHS","LU2087625088.SGD","CW","CEG","CRUS","AMG","BK4109","IE00BVYPNW00.USD","DG","CDNA","EGHT","BOWL","BK4208","BKNG","BK4178","LNG","CBT","LU2065169927.USD","CHE","CAR","IE00BKVL7J92.USD","LU1699723380.USD","CRGY","CNP","CMS","AWI","CRBG","AIG","CE","IRON","BCRX","CAMP","BFAM","CSTL","CC","AFL","CBLL"],"gpt_icon":1}],"profile":{"websiteUrl":"http://www.ceribell.com","stockEarnings":[{"period":"1week","weight":-0.0908},{"period":"1month","weight":0.0768},{"period":"3month","weight":0.5835},{"period":"ytd","weight":0.5835}],"compareEarnings":[{"period":"1week","weight":-0.0349},{"period":"1month","weight":-0.0032},{"period":"3month","weight":0.0268},{"period":"6month","weight":0.0767},{"period":"1year","weight":0.2347},{"period":"ytd","weight":0.2335}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"CeriBell, Inc.于2014年8月29日在特拉华州注册成立。他们是一家处于商业阶段的医疗技术公司,专注于改变严重神经系统疾病患者的诊断和管理。他们开发了Ceribell系统,这是一种新颖的护理点脑电图(“EEG”)平台,专门用于满足急性护理环境中患者未满足的需求。Ceribell系统将专有、高度便携、可快速部署的硬件与复杂的人工智能(“AI”)驱动的算法相结合,实现了对神经系统疾病患者的快速诊断和持续监测。Ceribell系统通过人工智能的力量使脑电图更容易获取并实现持续监测,使临床医生能够在急性护理环境中更快、更准确地诊断和管理有癫痫发作风险的患者,从而改善患者的预后以及医院和支付者的经济效益。","exchange":"NASDAQ","name":"Ceribell","nameEN":"Ceribell"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Ceribell(CBLL)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Ceribell(CBLL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Ceribell,CBLL,Ceribell股票,Ceribell股票老虎,Ceribell股票老虎国际,Ceribell行情,Ceribell股票行情,Ceribell股价,Ceribell股市,Ceribell股票价格,Ceribell股票交易,Ceribell股票购买,Ceribell股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Ceribell(CBLL)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Ceribell(CBLL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}